NICE does not currently have guidance on either AOD 9604 or retatrutide, reflecting their unlicensed and investigational status within the UK healthcare system
Additionally it was noted that in the rats treated with AOD9604, there were increased rates of lipolytic activity, as well as no negative effect on insulin sensitivity which has been seen in animals treated with human growth hormone ( A similar study conducted by Heffernan et
Our cutting-edge therapies, including peptide therapy, stem cell therapy, and PRP (Platelet-Rich Plasma) therapy, are designed to treat musculoskeletal injuries, arthritis, and enhance athletic performance and recovery
These pharmacokinetic differences inform the trade-offs in onset, convenience, and dosing convenience
By supplementing the ingredients our body naturally produces to regulate our metabolism, we can see greater results from our day-to-day diet and exercise plans